Published in Infect Immun on April 01, 2000
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun (2004) 2.78
Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect Immun (2002) 2.12
Tyrosine phosphorylation of the chlamydial effector protein Tarp is species specific and not required for recruitment of actin. Infect Immun (2005) 1.50
Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp. Antimicrob Agents Chemother (2005) 1.21
Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect Immun (2001) 1.13
Bioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatis. J Bacteriol (2007) 1.12
Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect Immun (2001) 1.08
A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1. Cell Microbiol (2009) 1.07
The expression, processing and localization of polymorphic membrane proteins in Chlamydia pneumoniae strain CWL029. BMC Microbiol (2002) 1.06
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci U S A (2012) 0.99
Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity. Infect Immun (2000) 0.98
Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun (2006) 0.96
Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells. Infect Immun (2005) 0.95
Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect Immun (2001) 0.90
Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model. J Clin Microbiol (2001) 0.90
Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells. Microbiology (2011) 0.88
Gene Deletion by Fluorescence-Reported Allelic Exchange Mutagenesis in Chlamydia trachomatis. MBio (2016) 0.88
Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarction. Am J Pathol (2007) 0.86
Kinematics of intracellular chlamydiae provide evidence for contact-dependent development. J Bacteriol (2009) 0.86
Biochemical and localization analyses of putative type III secretion translocator proteins CopB and CopB2 of Chlamydia trachomatis reveal significant distinctions. Infect Immun (2011) 0.86
The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged Sword. Front Immunol (2014) 0.85
Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations. Front Cell Infect Microbiol (2014) 0.85
Host cell responses to Chlamydia pneumoniae in gamma interferon-induced persistence overlap those of productive infection and are linked to genes involved in apoptosis, cell cycle, and metabolism. Infect Immun (2007) 0.84
Translation inhibition of the developmental cycle protein HctA by the small RNA IhtA is conserved across Chlamydia. PLoS One (2012) 0.82
Penicillin kills Chlamydia following the fusion of bacteria with lysosomes and prevents genital inflammatory lesions in C. muridarum-infected mice. PLoS One (2013) 0.80
Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis. J Antibiot (Tokyo) (2015) 0.80
Chlamydia pneumoniae impairs the innate immune response in infected epithelial cells by targeting TRAF3. J Immunol (2013) 0.79
Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque. Virchows Arch (2008) 0.79
AP-1 Transcription Factor Serves as a Molecular Switch between Chlamydia pneumoniae Replication and Persistence. Infect Immun (2015) 0.77
The Type III Secretion System-Related CPn0809 from Chlamydia pneumoniae. PLoS One (2016) 0.75
The High-Risk Human Papillomavirus E6 Oncogene Exacerbates the Negative Effect of Tryptophan Starvation on the Development of Chlamydia trachomatis. PLoS One (2016) 0.75
Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J Bacteriol (1970) 4.96
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A (1993) 4.28
Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J (1996) 4.02
Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis (1992) 3.49
Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30
Origins and functions of the chlamydial inclusion. Trends Microbiol (1997) 3.28
Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med (1996) 2.72
Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia. Infect Immun (1971) 2.63
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol (1988) 2.41
The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol (1999) 2.31
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis (1997) 2.06
Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis (1999) 1.91
Ultrastructural study of endocytosis of Chlamydia trachomatis by McCoy cells. Infect Immun (1988) 1.87
Ultrastructural study of mode of entry of Chlamydia psittaci into L-929 cells. Infect Immun (1986) 1.85
Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis? FEMS Microbiol Lett (1993) 1.56
Nucleotide sequence and taxonomic value of the major outer membrane protein gene of Chlamydia pneumoniae IOL-207. J Gen Microbiol (1991) 1.53
Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol (1999) 1.52
Patterns of response to sulfadiazine, D-cycloserine and D-alanine in members of the psittacosis group. J Infect Dis (1966) 1.36
Some consequences of the multiple infection of cell cultures by TRIC organisms. J Hyg (Lond) (1972) 1.36
Ultrastructural study of entry of Chlamydia strain TWAR into HeLa cells. Infect Immun (1988) 1.18
The morphology of Chlamydia pneumoniae. J Med Microbiol (1993) 1.14
Ultrastructure of Chlamydia pneumoniae in cell culture. FEMS Microbiol Lett (1991) 1.09
Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33
Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc Natl Acad Sci U S A (1981) 3.91
Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun (1996) 3.67
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A (1992) 3.61
A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A (2004) 3.44
Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae? J Bacteriol (1985) 3.23
Relationship between Energy-dependent Phosphate Uptake and the Electrical Membrane Potential in Lemna gibba G1. Plant Physiol (1981) 3.03
Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol (2000) 2.71
Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol Microbiol (1995) 2.64
Directional actin polymerization associated with spotted fever group Rickettsia infection of Vero cells. Infect Immun (1993) 2.59
Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J Cell Biol (1996) 2.49
Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity. Infect Immun (1985) 2.47
Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr (1998) 2.27
Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect Immun (1987) 2.25
SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci (1999) 2.21
Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol Microbiol (2000) 2.21
Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med (1998) 2.19
Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry. Infect Immun (1996) 2.18
Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol (1999) 2.18
Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol Microbiol (2001) 2.10
IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol (1991) 2.03
Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol Microbiol (2003) 2.03
Alcohol and drug disorders among physically abusive and neglectful parents in a community-based sample. Am J Public Health (1994) 1.96
Identification and properties of chlamydial polypeptides that bind eucaryotic cell surface components. J Bacteriol (1986) 1.93
Nucleoid condensation in Escherichia coli that express a chlamydial histone homolog. Science (1992) 1.87
A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci U S A (1996) 1.87
Reduced postoperative pancreatic fistula rate after pancreatogastrostomy versus pancreaticojejunostomy. J Gastrointest Surg (2008) 1.83
Chlamydia psittaci IncA is phosphorylated by the host cell and is exposed on the cytoplasmic face of the developing inclusion. Mol Microbiol (1997) 1.76
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol (1993) 1.73
Developmental biology of Coxiella burnettii. Trends Microbiol (1999) 1.65
Temporal analysis of the developing Chlamydia psittaci inclusion by use of fluorescence and electron microscopy. Infect Immun (1996) 1.65
Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg (1996) 1.65
Hypothermia during elective abdominal aortic aneurysm repair: the high price of avoidable morbidity. J Vasc Surg (1995) 1.64
High-risk intrahospital transport of critically ill patients: safety and outcome of the necessary "road trip". Crit Care Med (1995) 1.54
Effects of acid-base correction on hemodynamics, oxygen dynamics, and resuscitability in severe canine hemorrhagic shock. Crit Care Med (1994) 1.54
The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to low-molecular-weight compounds. Infect Immun (1997) 1.52
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51
Tandem genes of Chlamydia psittaci that encode proteins localized to the inclusion membrane. Mol Microbiol (1998) 1.48
Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates. Infect Immun (1986) 1.47
Molecular cloning and expression of hctB encoding a strain-variant chlamydial histone-like protein with DNA-binding activity. J Bacteriol (1993) 1.46
Effects of intravenous IL-8 administration in nonhuman primates. J Immunol (1992) 1.44
Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med (1991) 1.44
Acute acalculous cholecystitis. J Am Coll Surg (1995) 1.43
Effects of pentoxifylline on hemodynamics, oxygen transport, and tissue metabolism in experimental, severe hemorrhagic shock. Crit Care Med (1991) 1.41
Genetics and regulation of chitobiose utilization in Borrelia burgdorferi. J Bacteriol (2001) 1.41
Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells. Cell Microbiol (2001) 1.38
Descending aortic cannulation during emergent thoracotomy for blunt traumatic cardiac arrest. J Trauma (1999) 1.38
DNA polymorphism in the conserved 190 kDa antigen gene repeat region among spotted fever group Rickettsiae. Biochim Biophys Acta (1991) 1.35
Hc1-mediated effects on DNA structure: a potential regulator of chlamydial development. Mol Microbiol (1993) 1.35
The 120 kilodalton outer membrane protein (rOmp B) of Rickettsia rickettsii is encoded by an unusually long open reading frame: evidence for protein processing from a large precursor. Mol Microbiol (1991) 1.34
Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase. J Virol (1979) 1.33
Isolation and characterization of a mutant Chinese hamster ovary cell line that is resistant to Chlamydia trachomatis infection at a novel step in the attachment process. Infect Immun (2001) 1.29
A ninth complementation group in xeroderma pigmentosum, XP I. Mutat Res (1985) 1.26
Inhibition of lymphocyte proliferation by factor(s) produced by Schistosoma mansoni. Eur J Immunol (1977) 1.24
Stability of the adenosine 5'-triphosphate pool in Coxiella burnetii: influence of pH and substrate. J Bacteriol (1981) 1.24
Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes. Proc Natl Acad Sci U S A (1977) 1.22
Pollen-based quantitative reconstructions of Holocene regional vegetation cover (plant-functional types and land-cover types) in Europe suitable for climate modelling. Glob Chang Biol (2014) 1.21
Preparation of the FhuA (TonA) receptor protein from cell envelopes of an overproducing strain of Escherichia coli K-12. J Bacteriol (1986) 1.20
Occupational disease in New York State: a comprehensive examination. Am J Ind Med (1989) 1.19
pH dependence of the Coxiella burnetii glutamate transport system. J Bacteriol (1983) 1.18
Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells. J Virol (1978) 1.16
Estimation of the cytoplasmic pH of Coxiella burnetii and effect of substrate oxidation on proton motive force. J Bacteriol (1983) 1.16
Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol (2001) 1.15
Developmentally regulated synthesis of an unusually small, basic peptide by Coxiella burnetii. Mol Microbiol (1996) 1.14
Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol (1998) 1.14
Intestinal sugar transport in experimental diabetes. Diabetes (1981) 1.13
Inhibition of fusion of Chlamydia trachomatis inclusions at 32 degrees C correlates with restricted export of IncA. Infect Immun (2002) 1.12
Improving biological control by combining biocontrol agents each with several mechanisms of disease suppression. Phytopathology (2002) 1.12
Induction of cell-associated interleukin 1 through stimulation of the adhesion-promoting proteins LFA-1 (CD11a/CD18) and CR3 (CD11b/CD18) of human monocytes. Eur J Immunol (1990) 1.11
Effect of proteolytic cleavage of surface-exposed proteins on infectivity of Chlamydia trachomatis. Infect Immun (1985) 1.11
[Arrhythmias and symptoms during long-term ECG in ambulatory patients]. Schweiz Rundsch Med Prax (1984) 1.09
The elongation factor Tu binds aminoacyl-tRNA in the presence of GDP. J Biol Chem (1982) 1.09
Terrestrial and aquatic mammals of the Pantanal. Braz J Biol (2011) 1.08
Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect Immun (2001) 1.08
Spontaneous in vitro malignant transformation in a xeroderma pigmentosum fibroblast line. Int J Cancer (1983) 1.08
Rickettsia rickettsii growth and temperature-inducible protein expression in embryonic tick cell lines. J Med Microbiol (1997) 1.07
Natural autoantibodies and complement promote the uptake of a self antigen, human thyroglobulin, by B cells and the proliferation of thyroglobulin-reactive CD4(+) T cells in healthy individuals. Eur J Immunol (2001) 1.01
Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p150,95 in a girl with recurrent bacterial infections. Effects on phagocytic cells and lymphocyte functions. J Clin Invest (1985) 1.01
Biosafety concerns and Coxiella burnetii. Trends Microbiol (1996) 1.00
[Analytical characterization of palatinit (author's transl)]. Z Lebensm Unters Forsch (1979) 1.00
Radical changes to chlamydial taxonomy are not necessary just yet. Int J Syst Evol Microbiol (2001) 0.99
Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c. Scand J Immunol (1988) 0.98
Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes. J Immunol (1987) 0.98
Blood transfusion-induced suppression of cellular immunity in man. Hum Immunol (1980) 0.98
Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest (1997) 0.98
Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor. J Immunol (1986) 0.97
Inhibition of complement activation by natural sulfated polysaccharides (fucans) from brown seaweed. Mol Immunol (1994) 0.97
A developmental stage-specific histone H1 homolog of Coxiella burnetii. J Bacteriol (1996) 0.97
Health costs of occupational disease in New York State. Am J Ind Med (1989) 0.97
Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand J Immunol (1993) 0.96
One-year survival and neurological outcome after pediatric cardiopulmonary resuscitation. Intensive Care Med (2002) 0.96
Substance use and sexual risk behaviour among HIV-positive men who have sex with men in specialized out-patient clinics. HIV Med (2012) 0.96
Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells. J Immunol (1991) 0.96
Localization of the chaperone domain of FKBP52. J Biol Chem (2001) 0.95
Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii. Infect Immun (1988) 0.95
Mouse monoclonal antibodies to the human C3b receptor. Mol Immunol (1985) 0.94
Overproduction of the proFhuA outer membrane receptor protein of Escherichia coli K-12: isolation, properties, and immunocytochemical localization at the inner side of the cytoplasmic membrane. Arch Microbiol (1986) 0.94
Identification of surface molecules on salivary glands of the mosquito, Aedes aegypti, by a panel of monoclonal antibodies. Insect Biochem Mol Biol (1999) 0.94